Does HRV Biofeedback Work for Long COVID? The Evidence
Slow resonant breathing is one of the gentlest things you can try for long COVID dysautonomia. Here is what the actual studies found, where they fall short, and how to judge whether it is worth your energy.
If you have long COVID and a dysregulated nervous system, you have probably been told to “just breathe” more times than you can count. It is worth asking a fairer question: when researchers actually studied slow, paced breathing and HRV biofeedback in long COVID, what did they find?
What the intervention actually is
HRV biofeedback is a specific practice, not a vibe. You breathe slowly and evenly, usually around five to six breaths per minute, while watching a signal (a pacer, or your live heart rate) that helps you find the pace where your heart rate swings most smoothly with each breath. At that “resonance frequency,” breath, heart rate and blood pressure fall into step, and your heart rate variability rises sharply while you do it.
The mechanics and a concrete protocol live in the companion piece on resonant breathing and HRV biofeedback; if HRV itself is new to you, start with the complete guide to HRV. Here we are only asking one thing: does the evidence support it for long COVID specifically?
Why long COVID is a reasonable target
There is a plausible mechanism. Long COVID is strongly associated with autonomic dysfunction, the same family of problems behind POTS and post-viral dysautonomia, which is why the conditions overlap so heavily. One consistent finding is blunted heart rate variability. In a case-control study, people with long COVID showed reduced HRV both at rest and during deep-breathing maneuvers compared with controls, suggesting the parasympathetic “brake” is under-responsive.
If the vagal brake is weak, an intervention that directly exercises it, slow breathing at resonance, is at least a sensible thing to test. That is the logic behind the studies below.
What the studies actually found
Here is the current evidence, laid out honestly. Read the caveat column as carefully as the finding column.
| Study / finding | What it looked at | What it found | Caveat |
|---|---|---|---|
| HEARTLOC feasibility study | A home-delivered HRV-biofeedback breathing programme for people with long COVID dysautonomia | The programme was feasible and acceptable to deliver at home, with promising early signals on symptoms | A feasibility study, not an efficacy trial: small, designed to test whether the approach is practical, not to prove it works |
| Resonant breathing pilot | Slow resonant breathing practiced by people with long COVID | Participants reported improved symptoms and wellbeing | Small sample, mostly self-reported outcomes, and a preprint. Findings can shift after peer review |
| HRV in long COVID | Resting HRV and HRV during deep breathing, long COVID vs controls | Long COVID was linked to blunted HRV, including during deep-breathing maneuvers | Observational: shows an association and a target, not that breathing training fixes it |
The honest limits
It would be easy to read the table above and conclude the case is closed. It is not. A few things keep this in the “promising, not proven” column:
- Small and early. These are feasibility and pilot studies, often with a few dozen participants and frequently no control group.
- Self-reported outcomes. Feeling better matters enormously, but symptom and wellbeing scores are especially vulnerable to placebo and expectation effects, which loom large for a hands-on practice you actively do.
- Few randomized controlled trials. Without randomization and a comparison group, you cannot cleanly separate the breathing from natural recovery, attention, or hope.
- Risk of bias. Small single-arm studies tend to over-estimate effects. Bigger, blinded trials usually shrink them.
None of this means breathing “does not work.” It means the science has not yet earned the confidence of a first-line, guideline-backed treatment. Both things can be true: many people feel real relief, and the evidence base is still thin.
Who should be cautious
For most people slow breathing is about as low-risk as an intervention gets: no cost beyond a few minutes, nothing to swallow, nothing to injure. But it is not zero-risk for every nervous system.
The balanced takeaway
So, does HRV biofeedback work for long COVID? The fair answer: it is plausible, low-cost, low-risk, and backed by early studies that point the right way, but it has not yet been proven in the kind of large randomized trials that would make it a standard treatment. For a symptom you might otherwise be told nothing can be done about, a gentle, cheap practice with a real mechanism and encouraging pilot data is a reasonable thing to try.
The catch with early evidence is that group averages do not tell you about you. This is exactly where treating your own body as the experiment helps. If you decide to try resonant breathing, it belongs alongside the other tools that actually have your data behind them, the same logic as pacing to your energy envelope or the broader “what works” view of raising HRV.
How Autonomic helps
The honest limits above are a research problem, but they are also your problem in miniature: how do you know if breathing is doing anything for you, not just for a study population? You watch your own trend. Autonomic logs your HRV readings, scores each one against its zone, and shows the direction over weeks rather than the noise of a single morning, so if a daily breathing practice is nudging your baseline, you will see it, and if it is not, you will not waste months guessing.
The bottom line
HRV biofeedback for long COVID is a genuinely promising idea with genuinely early evidence. Feasibility and pilot studies say it is practical, tolerable, and linked to feeling better; they do not yet say it is a cure or a proven therapy. If you go in with that expectation (a gentle support to test, tracked against your own baseline, never a replacement for care), you are reading the science exactly as it stands.
Frequently asked questions
Does HRV biofeedback work for long COVID?+
The early evidence is encouraging but not conclusive. Small feasibility and pilot studies in people with long COVID and post-viral dysautonomia found HRV biofeedback and slow-paced breathing to be practical, well tolerated, and associated with improvements in self-reported symptoms and wellbeing. What is missing is large, randomized, placebo-controlled trials, so it is best understood as a promising, low-risk support rather than a proven treatment.
Is there evidence that breathing exercises help long COVID?+
Yes, though it is early-stage. A home HRV-biofeedback breathing programme for long COVID dysautonomia was found feasible with promising symptom signals, and a separate pilot study reported that resonant breathing improved symptoms and wellbeing. These are small studies with mostly self-reported outcomes, so they suggest a real signal without proving cause and effect.
How strong is the research on resonant breathing?+
Modest. The studies to date are small, often single-arm feasibility or pilot trials, rely heavily on self-reported outcomes, and carry a meaningful risk of bias, including placebo and expectation effects. That does not mean it does not help (many people clearly feel better), but the science is not yet at the level of a first-line, evidence-backed treatment.
Is HRV biofeedback safe?+
For most people it is very safe and low-cost. The main cautions are practical: some people with dysautonomia feel air-hungry, dizzy or more anxious when they first slow their breathing. Start with short seated sessions, keep the breathing gentle rather than forced, and stop if it makes you feel worse. It should complement, not replace, medical care.
Track your recovery with Autonomic
A private, offline journal that scores your daily HRV, BP and orthostatic readings against medical thresholds. Free to download, with $7.99/mo Pro when you want the deep-analysis tools.
Download on the App Store